Asset Details
Do you wish to reserve the book?
Pulmonary Disease Caused by Non-Tuberculous Mycobacteria
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Pulmonary Disease Caused by Non-Tuberculous Mycobacteria
Do you wish to request the book?
Pulmonary Disease Caused by Non-Tuberculous Mycobacteria
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Pulmonary Disease Caused by Non-Tuberculous Mycobacteria
2016
Overview
Non-tuberculous mycobacteria (NTM) include more than 160 ubiquitous, environmental, acid-fast-staining bacterial species, some of which may cause disease in humans. Chronic pulmonary infection is the most common clinical manifestation. Although patients suffering from chronic lung diseases are particularly susceptible to NTM pulmonary disease, many affected patients have no apparent risk factors. Host and pathogen factors leading to NTM pulmonary disease are not well understood and preventive therapies are lacking. NTM isolation and pulmonary disease are reported to rise in frequency in Europe as well as in other parts of the world. Differentiation between contamination, infection, and disease remains challenging. Treatment of NTM pulmonary disease is arduous, lengthy, and costly. Correlations between results of in vitro antibiotic susceptibility testing and clinical treatment outcomes are only evident for the Mycobacterium avium complex, M. kansasii, and some rapidly growing mycobacteria. We describe the epidemiology of NTM pulmonary disease as well as emerging NTM pathogens and their geographical distribution in non-cystic fibrosis patients in Europe. We also review recent innovations for the diagnosis of NTM pulmonary disease, summarize treatment recommendations, and identify future research priorities to improve the management of patients affected by NTM pulmonary disease.
Publisher
S. Karger AG,Karger
Subject
/ Complications and side effects
/ HIV
/ Human immunodeficiency virus
/ Humans
/ Mycobacterium avium-intracellulare Infection - diagnosis
/ Mycobacterium avium-intracellulare Infection - drug therapy
/ Mycobacterium avium-intracellulare Infection - epidemiology
/ Mycobacterium Infections, Nontuberculous - diagnosis
/ Mycobacterium Infections, Nontuberculous - drug therapy
/ Mycobacterium Infections, Nontuberculous - epidemiology
/ Mycobacterium Infections, Nontuberculous - microbiology
/ Review
/ Tuberculosis, Pulmonary - diagnosis
/ Tuberculosis, Pulmonary - drug therapy
